Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
69.1M
-
Number of holders
-
165
-
Total 13F shares, excl. options
-
52.1M
-
Shares change
-
-49K
-
Total reported value, excl. options
-
$755M
-
Value change
-
-$40.3M
-
Put/Call ratio
-
6.16
-
Number of buys
-
108
-
Number of sells
-
-76
-
Price
-
$14.49
Significant Holders of Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) as of Q2 2022
215 filings reported holding HCAT - Health Catalyst, Inc. - Common Stock, par value $0.001 per share as of Q2 2022.
Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) has 165 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 52.1M shares
of 69.1M outstanding shares and own 75.38% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5.31M shares), BlackRock Inc. (4.74M shares), ALLIANCEBERNSTEIN L.P. (4.46M shares), WELLINGTON MANAGEMENT GROUP LLP (2.7M shares), Clearbridge Investments, LLC (2.13M shares), GOLDMAN SACHS GROUP INC (1.43M shares), abrdn plc (1.42M shares), AMERICAN CENTURY COMPANIES INC (1.31M shares), JANUS HENDERSON GROUP PLC (1.23M shares), and First Light Asset Management, LLC (1.14M shares).
This table shows the top 165 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.